Founded in 2016 with a $250 million donation from Silicon Valley entrepreneur Sean Parker, the Parker Institute for Cancer Immunotherapy (PICI) is a San Francisco-based nonprofit dedicated to transforming cancer research. Its core mission is to accelerate the development of breakthrough immunotherapies by fostering unprecedented collaboration among leading research institutions, scientists, and industry partners. PICI focuses on creating innovative treatments that harness the power of the immune system to combat cancer, aiming to make these therapies accessible to patients worldwide.
Notable affiliated individuals include Sean Parker, whose vision and funding were instrumental in establishing PICI. The institute collaborates with top-tier research centers such as Memorial Sloan Kettering Cancer Center and Stanford University. Key achievements include advancing numerous clinical trials and fostering significant scientific discoveries in cancer immunotherapy. PICI's collaborative model has had a profound impact on the field, driving forward new treatments and offering hope to millions affected by cancer.